BusinessAnavex Life Sciences Presents New Clinical Data of Investigational Alzheimer’s Disease Treatment ANAVEX®2-73 at 2017 Clinical Trials on Alzheimer’s Disease MeetingBy Nasdaq OMXNov 4, 2017, 7:30 PM UTC
BusinessAquaBounty Technologies, Inc. Results for the quarter ended September 30, 2017By Nasdaq OMXNov 2, 2017, 8:30 PM UTC
BusinessCorvus Pharmaceuticals Reports Third Quarter 2017 Financial Results and Clinical Program UpdateBy Nasdaq OMXNov 2, 2017, 8:10 PM UTC
BusinessApricus Biosciences Provides Corporate Update and Third Quarter 2017 Financial ResultsBy Nasdaq OMXNov 2, 2017, 8:01 PM UTC
BusinessArbutus Announces Corporate Update and Third Quarter 2017 Financial ResultsBy Nasdaq OMXNov 2, 2017, 8:00 PM UTC
BusinessAnthera Pharmaceuticals Announces Presentations of Sollpura Data at the North American Cystic Fibrosis ConferenceBy Nasdaq OMXNov 2, 2017, 12:30 PM UTC
BusinessNewLink Genetics Reports Third Quarter 2017 Financial Results and Updates Indoximod ProgramBy Nasdaq OMXNov 2, 2017, 12:02 PM UTC
BusinessMyriad Announces GeneSight® Psychotropic Results from a Large Prospective Trial in Patients with Major Depressive DisorderBy Nasdaq OMXNov 2, 2017, 11:05 AM UTC
